Literature DB >> 17998328

Crohn's disease or abdominal tuberculosis?

.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17998328      PMCID： PMC2095700          DOI： 10.1136/gut.2007.138875

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  44 in total

1.  Predictability of the postoperative course of Crohn's disease.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; J Beyls; R Kerremans; M Hiele
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

2.  Red blood cell volume distributions and the diagnosis of anemia. Help or hindrance?

Authors:  G M Brittenham; J A Koepke
Journal:  Arch Pathol Lab Med       Date:  1987-12       Impact factor: 5.534

3.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

4.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  Transabdominal ultrasonography as the primary investigation in patients with suspected Crohn's disease or recurrence: a prospective study.

Authors:  M B Sheridan; D A Nicholson; D F Martin
Journal:  Clin Radiol       Date:  1993-12       Impact factor: 2.350

6.  Primary and recurrent Crohn's disease. Experience with 1379 patients.

Authors:  F Michelassi; T Balestracci; R Chappell; G E Block
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

Review 7.  Medical marijuana: emerging applications for the management of neurologic disorders.

Authors:  Gregory T Carter; Vivian Ugalde
Journal:  Phys Med Rehabil Clin N Am       Date:  2004-11       Impact factor: 1.784

8.  Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

Authors:  Sandro Ardizzone; Giovanni Maconi; Gianluca M Sampietro; Antonio Russo; Elisa Radice; Elisabetta Colombo; Venerina Imbesi; Mirko Molteni; Pier Giorgio Danelli; Angelo M Taschieri; Gabriele Bianchi Porro
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

9.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Authors:  Stephen B Hanauer; Burton I Korelitz; Paul Rutgeerts; Mark A Peppercorn; Ronald A Thisted; Russell D Cohen; Daniel H Present
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

10.  Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.

Authors:  G R Greenberg; B G Feagan; F Martin; L R Sutherland; A B Thomson; C N Williams; L G Nilsson; T Persson
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.